Helen L. Leavis

5.1k citations

69 papers · 2.2k indexed · 1 hit paper · h-index 22

Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 6
Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 17
Molecular Medicine top 5%
Microbiology top 5%
Periodontics top 5%
Immunology
- Immunodeficiency and Autoimmune Disorders 20
- Immune Cell Function and Interaction 7
Physiology
- Salivary Gland Disorders and Functions 8
Rheumatology
- Systemic Lupus Erythematosus Research 8
Molecular Biology
- Bacterial biofilms and quorum sensing 6
Pulmonary and Respiratory Medicine
- Cystic Fibrosis Research Advances 6

Co-authors: Rob J. L. Willems Marc J. M. Bonten Marc JM Bonten Janetta Top Fernanda L. Paganelli Willem van Schaik Willem J. B. van Wamel Frank Schuren
Cited by: Clinical Biochemistry Infectious Diseases Molecular Medicine
Journals: Nature Medicine (1 paper)Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)
Partner nations: Netherlands Germany United States

In The Last Decade

Helen L. Leavis

59 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Helen L. Leavis

Since Specialization

Citations

This map shows the geographic impact of Helen L. Leavis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen L. Leavis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen L. Leavis more than expected).

Fields of papers citing papers by Helen L. Leavis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen L. Leavis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen L. Leavis. The network helps show where Helen L. Leavis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Helen L. Leavis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helen L. Leavis Line = papers co-authored together Helen L. Leavis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CVID Enteropathy Is Difficult To Treat and Shows a Heterogeneous Histopathology Journal of Clinical Immunology ·Norsham Juliana,Mirjam Severs,J. Marsden,Joris M. van Montfrans,Pauline M. Ellerbroek,Miangela M. Laclé,Virgil A. S. H. Dalm,Amir Abelmoumen,Helen L. Leavis	2025	0
2	Disseminated histoplasmosis induced hemophagocytic lymphohistiocytosis in an immunocompromised patient Clinical Infection in Practice ·N.El Bardai,Laura M. Vos,Helen L. Leavis,Margot Jak,Anke H. W. Bruns,Maarten Limper	2025	0
3	Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency The Journal of Allergy and Clinical Immunology In Practice ·Bas M. Smits,Sharisa L. Boland,Marjolein E Hol,Rana Dandis,Helen L. Leavis,Pim A. de Jong,Sabine M. P. J. Prevaes,Firdaus A. A. Mohamed Hoesein,Joris M. van Montfrans,Pauline M. Ellerbroek	2024	2
4	Paucity of gastrointestinal plasma cells in common variable immunodeficiency Current Opinion in Allergy and Clinical Immunology ·J. Marsden,Miangela M. Laclé,Mirjam Severs,Helen L. Leavis	2024	4
5	The PID Odyssey 2030: outlooks, unmet needs, hurdles, and opportunities — proceedings from the IPOPI global multi-stakeholders’ summit (June 2022) Frontiers in Immunology ·Susan Tadros,J Prévot,Isabelle Meyts,Silvia Sánchez‐Ramón,Nahla H. Erwa,Alain Fischer,Guillaume Lefèvre,Matthew Hotchko,Peter Jaworski,Helen L. Leavis,Cornelis Boersma,Jose Drabwell,Martin van Hagen,Samya Van Coillie,Martine Pergent,Siobhan O. Burns,Nizar Mahlaoui	2023	2
6	OP0215 IMMUNOME ANALYSIS INDICATES ROBUST INHIBITION OF PROINFLAMMATORY MEDIATORS UPON LEFLUNOMIDE-HYDROXYCHLOROQUINE COMBINATION THERAPY IN SJÖGREN'S SYNDROME: CXCR3 LIGANDS AS POTENTIAL INFLAMMATORY ENDOTYPE BIOMARKERS. Annals of the Rheumatic Diseases ·Valentin Baloche,C. Bogers,Helen L. Leavis,J. Van Roon	2023	0
7	Soluble Signal Inhibitory Receptor on Leukocytes-1 Is Released from Activated Neutrophils by Proteinase 3 Cleavage The Journal of Immunology ·Helen J. von Richthofen,Geertje H. A. Westerlaken,Doron Gollnast,Sjanna B. Besteman,Eveline M. Delemarre,Karlijn Rodenburg,Petra Moerer,Daphne A. C. Stapels,Anand Kumar Andiappan,Olaf Rötzschke,Stefan Nierkens,Helen L. Leavis,Louis Bont,Suzan H. M. Rooijakkers,Linde Meyaard	2023	7
8	AB1468 ENTEROPATHY IN DUTCH COMMON VARIABLE IMMUNODEFICIENCY COHORT Norsham Juliana,Mirjam Severs,Jacques van Montfrans,Pauline M. Ellerbroek,Bas Oldenburg,J. Van Roon,Helen L. Leavis	2023	1
9	Prolonged Disease Course of COVID-19 in a Patient with CTLA-4 Haploinsufficiency SHILAP Revista de lepidopterología ·Thijs W. Hoffman,Helen L. Leavis,Bas M. Smits,Lars T. van der Veken,Diana A. van Kessel	2023	0
10	Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts Lara D. Veeken ·Helen L. Leavis,Paul Van Daele,Catharina M. Mulders‐Manders,Renée Michels,Abraham Rutgers,G. Elizabeth Legger,Marc Bijl,Elisabeth A Hak,Wai‐Kwan Lam‐Tse,Femke Bonte‐Mineur,Peter Fretter,Anna Simon,Pieter van Paassen,Marlies C. van der Goes,Marcel Flendrie,Ward Vercoutere,Antoine W.T. van Lieshout,A. Leek,Sebastiaan J. Vastert,Sander W. Tas	2023	16
11	Development of a primary care screening algorithm for the early detection of patients at risk of primary antibody deficiency Allergy Asthma and Clinical Immunology ·Marianne A. Messelink,Roos M. Berbers,Joris M. van Montfrans,Pauline M. Ellerbroek,André Gladiator,Paco M J Welsing,Helen L. Leavis	2023	6
12	A guide to immunotherapy for COVID-19breakdown → Nature Medicine ·Frank L. van de Veerdonk,Evangelos J. Giamarellos‐Bourboulis,Peter Pickkers,Lennie Derde,Helen L. Leavis,Reinout van Crevel,Job J. Engel,W. Joost Wiersinga,Alexander P. J. Vlaar,Manu Shankar‐Hari,Tom van der Poll,Marc J. M. Bonten,Derek Angus,J.W.M. van der Meer,Mihai G. Netea	2022	191
13	Severe thrombotic microangiopathy after autologous stem cell transplantation in systemic sclerosis: a case report Lara D. Veeken ·Maryam Sharif,Helen L. Leavis,Pieter van Paassen,Anna van Rhenen,Sjoerd A.M.E.G. Timmermans,Evelien Ton,Jacob M. van Laar,Julia Spierings	2021	3
14	Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS Journal of Allergy and Clinical Immunology ·Caspar I. van der Made,Judith Potjewijd,Annemiek Hoogstins,Huub P J Willems,Arjan J. Kwakernaak,Ruud G.L. de Sévaux,Paul Van Daele,Annet Simons,Marloes W Heijstek,David B. Beck,Mihai G. Netea,Pieter van Paassen,A. Elizabeth Hak,Lars T. van der Veken,Mariëlle van Gijn,Alexander Hoischen,Frank L. van de Veerdonk,Helen L. Leavis,Abraham Rutgers	2021	128
15	Case series of three adult patients with exceptional clinical presentations of haemophagocytic lymphohistiocytosis. The Netherlands Journal of Medicine ·Meriem Khairoun,F.M.C.J. Meynen,Ward Vercoutere,Helen L. Leavis	2020	3
16	Group IIA-Secreted Phospholipase A ₂ in Human Serum Kills Commensal but Not Clinical Enterococcus faecium Isolates Infection and Immunity ·Fernanda L. Paganelli,Helen L. Leavis,Samantha He,Nina M. van Sorge,Christine Payré,Gérard Lambeau,Rob J. L. Willems,Suzan H. M. Rooijakkers	2018	12
17	Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy? PubMed ·Henny G. Otten,Walter J. Brummelhuis,Ruth Fritsch‐Stork,Helen L. Leavis,Bram W. Wisse,J.M. van Laar,Ronald H. W. M. Derksen	2017	10
18	The Enterococcus faecium Enterococcal Biofilm Regulator, EbrB, Regulates the esp Operon and Is Implicated in Biofilm Formation and Intestinal Colonization PLoS ONE ·Janetta Top,Fernanda L. Paganelli,Xinglin Zhang,Willem van Schaik,Helen L. Leavis,Miranda van Luit‐Asbroek,Tom van der Poll,Masja Leendertse,Marc J. M. Bonten,Rob J. L. Willems	2013	28
19	Insertion Sequence–Driven Diversification Creates a Globally Dispersed Emerging Multiresistant Subspecies of E. faecium PLoS Pathogens ·Helen L. Leavis,Rob J. L. Willems,Willem J. B. van Wamel,Frank Schuren,Martien P. M. Caspers,Marc J. M. Bonten	2007	163
20	Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance Current Opinion in Microbiology ·Helen L. Leavis,Marc JM Bonten,Rob J. L. Willems	2006	252

About Helen L. Leavis

Helen L. Leavis is a scholar working on Infectious Diseases, Immunology and Clinical Biochemistry, having authored 69 papers that have together received 2.2k indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (20 papers), Antimicrobial Resistance in Staphylococcus (17 papers), Salivary Gland Disorders and Functions (8 papers), Systemic Lupus Erythematosus Research (8 papers), Immune Cell Function and Interaction (7 papers), Bacterial biofilms and quorum sensing (6 papers), Cystic Fibrosis Research Advances (6 papers) and Bacterial Identification and Susceptibility Testing (6 papers). The work is most often cited by research in Clinical Biochemistry (531 citations), Infectious Diseases (1.1k citations) and Molecular Medicine (129 citations). Helen L. Leavis has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Rob J. L. Willems, Marc J. M. Bonten, Marc JM Bonten, Janetta Top, Fernanda L. Paganelli, Willem van Schaik, Willem J. B. van Wamel, Frank Schuren, Martien P. M. Caspers and Nathan Shankar. Their work appears in journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact